Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Landos lands $60m
Osage University Partners is among the series B investors backing Virginia Tech-linked IBD therapy disease developer Landos Biopharma, which is preparing phase 2 trials.
Carisma dazzles with extended series A
The spinout has revealed it added approximately $6m to a series A round backed by University of Pennsylvania and IP Group last year, bringing its total size to about $59m.
HawkEye 360 beams in $70m
Allied Minds has returned again for a series B round that took the firm's geospatial data analytics technology subsidiary's total funding to about $96m.
Alizé Pharma 3 leads corporates to series A
Novo, Partners Healthcare and Sham all contributed to a $74.6m round for Alizé Pharma 3, which is exploiting research from three US institutions.
Synspective secures series A funding
UTokyo IPC, Keio Innovation Initiative and Innovations and Future Creation have contributed to a $79.7m series A that increased the Tokyo spinout's total funding to about $100m.
TScan takes in $48m
Harvard Medical School spinout TScan has come out of stealth with $48m in funding provided by investors including GV and two Novartis units.
X-Vax packs $56m into series A
Johnson & Johnson, Alexandria Venture Investments and Serum Institute of India contributed to a series A for Albert Einstein College of Medicine spinout X-Vax.
Bolt puts $68m in its basket
A host of individuals connected with the e-commerce industry have supplied capital, enabling Stanford-linked company Bolt to target its next phase of expansion.

Other News

Menlo Security decrypts $75m series D
Building on UC Berkeley research, cybersecurity software company Menlo Security has now raised approximately $150m altogether.
Oxford PV locks in series D close
University of Oxford's solar cell technology developer Oxford PV has closed a series D round featuring Meyer Burger, Equinor and Legal & General at $81.8m.
Lundbeck signs up for Sanifit’s series D
University of the Balearic Islands spinout Sanifit has raised $62.8m in a series D round backed by existing backer Lundbeckfonden Ventures to bring its overall financing to $149m.
Frontier faces down $67m
Frontier Medicines, based on UC Berkeley research, has launched with $67m in series A funding co-led by Deerfield Management, MPM Capital and Droia Oncology Ventures.
Booster puts $56m into series C tank
Booster, a fuel delivery service backed by Stanford-StartX Fund, has collected $56m in series C funding from investors including Enterprise Holdings and Total.
SiFive siphons $65.4m series D
UC Berkeley's custom semiconductor spinout has now raised $125m, after Qualcomm Ventures joined existing investors such as Osage University Partners for a $65.4m series D round.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Big deal: Touchstone helps inject $73m into Cell Medica
Touchstone Innovations, which co-founded the cellular immunotherapy developer in 2007, has contributed to another funding round.
test reg